Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ).
Cluster Headache Impact Questionnaire
Cluster headache
Disability
Quality of life
Questionnaire
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
19
02
2023
accepted:
14
03
2023
medline:
17
7
2023
pubmed:
21
3
2023
entrez:
20
3
2023
Statut:
ppublish
Résumé
The Cluster Headache Impact Questionnaire (CHIQ) is a specific and easy-to-use questionnaire to assess the current impact of cluster headache (CH). The aim of this study was to validate the Italian version of the CHIQ. We included patients diagnosed with episodic CH (eCH) or chronic CH (cCH) according to the ICHD-3 criteria and included in the "Italian Headache Registry" (RICe). The questionnaire was administered to patients through an electronic form in two sessions: at first visit for validation, and after 7 days for test-retest reliability. For internal consistency, Cronbach's alpha was calculated. Convergent validity of the CHIQ with CH features and the results of questionnaires assessing anxiety, depression, stress, and quality of life was evaluated using Spearman's correlation coefficient. We included 181 patients subdivided in 96 patients with active eCH, 14 with cCH, and 71 with eCH in remission. The 110 patients with either active eCH or cCH were included in the validation cohort; only 24 patients with CH were characterized by a stable attack frequency after 7 days, and were included in the test-retest cohort. Internal consistency of the CHIQ was good with a Cronbach alpha value of 0.891. The CHIQ score showed a significant positive correlation with anxiety, depression, and stress scores, while showing a significant negative correlation with quality-of-life scale scores. Our data show the validity of the Italian version of the CHIQ, which represents a suitable tool for evaluating the social and psychological impact of CH in clinical practice and research.
Sections du résumé
BACKGROUND
BACKGROUND
The Cluster Headache Impact Questionnaire (CHIQ) is a specific and easy-to-use questionnaire to assess the current impact of cluster headache (CH). The aim of this study was to validate the Italian version of the CHIQ.
METHODS
METHODS
We included patients diagnosed with episodic CH (eCH) or chronic CH (cCH) according to the ICHD-3 criteria and included in the "Italian Headache Registry" (RICe). The questionnaire was administered to patients through an electronic form in two sessions: at first visit for validation, and after 7 days for test-retest reliability. For internal consistency, Cronbach's alpha was calculated. Convergent validity of the CHIQ with CH features and the results of questionnaires assessing anxiety, depression, stress, and quality of life was evaluated using Spearman's correlation coefficient.
RESULTS
RESULTS
We included 181 patients subdivided in 96 patients with active eCH, 14 with cCH, and 71 with eCH in remission. The 110 patients with either active eCH or cCH were included in the validation cohort; only 24 patients with CH were characterized by a stable attack frequency after 7 days, and were included in the test-retest cohort. Internal consistency of the CHIQ was good with a Cronbach alpha value of 0.891. The CHIQ score showed a significant positive correlation with anxiety, depression, and stress scores, while showing a significant negative correlation with quality-of-life scale scores.
CONCLUSION
CONCLUSIONS
Our data show the validity of the Italian version of the CHIQ, which represents a suitable tool for evaluating the social and psychological impact of CH in clinical practice and research.
Identifiants
pubmed: 36939946
doi: 10.1007/s10072-023-06758-0
pii: 10.1007/s10072-023-06758-0
pmc: PMC10345064
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2845-2851Informations de copyright
© 2023. The Author(s).
Références
J Headache Pain. 2022 Mar 18;23(1):37
pubmed: 35303796
Front Neurol. 2020 Nov 10;11:597881
pubmed: 33240213
BMJ. 1992 Jul 18;305(6846):160-4
pubmed: 1285753
Cephalalgia. 2008 Jun;28(6):614-8
pubmed: 18422717
J Headache Pain. 2016 Dec;17(1):79
pubmed: 27596922
Lancet Neurol. 2018 Jan;17(1):75-83
pubmed: 29174963
Cephalalgia. 2020 Oct;40(11):1240-1249
pubmed: 32484060
Headache. 2012 Jan;52(1):99-113
pubmed: 22077141
Pharmacoeconomics. 2002;20(11):715-25
pubmed: 12201791
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Behav Res Ther. 1995 Mar;33(3):335-43
pubmed: 7726811
Curr Pain Headache Rep. 2013 Feb;17(2):313
pubmed: 23296640